Record 3 of 3
Record:   Prev Next
Title Transparency in health and health care in the United States : law and ethics / edited by Holly Fernandez Lynch, University of Pennsylvania, Perelman School of Medicine, I. Glenn Cohen, Petrie-Flom Center, Harvard Law School, Carmel Shachar, Petrie-Flom Center, Harvard Law School, Barbara J. Evans, University of Houston Law Center
Imprint Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
book jacket
 人文社會聯圖  KF3821 .T73 2019    AVAILABLE    30660020219197
Descript xv, 356 pages ; 24 cm
text txt rdacontent
unmediated n rdamedia
volume nc rdacarrier
Note "Transparency is a concept that is becoming increasingly lauded as a solution to a host of problems in the American health care system. Transparency initiatives show great promise, including empowering patients and other stakeholders to make more efficient decisions, improve resource allocation, and better regulate the health care industry. Nevertheless, transparency is not a cure-all for the problems facing the modern health care system. The authors of this volume present a nuanced view of transparency, exploring ways in which transparency has succeeded and ways in which transparency initiatives have room for improvement. Working at the intersection of law, medicine, ethics, and business, the book goes beyond the buzzwords to the heart of transparency's transformative potential, while interrogating its obstacles and downsides. It should be read by anyone looking for a better understanding of transparency in the health care context"-- Provided by publisher
"Transparency is a relatively new concept to the world of health and health care, considering that just a few decades ago we were still in the throes of a "doctor-knows- best" model. Today, however, transparency is front and center on almost every list of solutions to a variety of health policy problems, ranging from conflicts of interest to rising drug costs to promoting efficient use of health care resources, and more. Doctors are now expected to be transparent about patient diagnoses and treatment options, hospitals are expected to be transparent about error rates, insurers about policy limitations, companies about prices, researchers about data, and policymakers about priorities and rationales for health policy intervention"-- Provided by publisher
Includes bibliographical references
Introduction / Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch and Barbara J. Evans -- Introduction to part I / Abigail R. Moncrieff -- Smashing into windows: 'the limits of consumer sovereignty in health care' / Barry R. Furrow -- The interplay of privacy and transparency in health care: the HIPAA privacy rule as a case study / Barbara J. Evans -- Transparency trade-offs: priority-setting, scarcity, and health fairness / Govind Persad -- Slightly hazy: transparency and the costs of too much information / Oliver J. Kim -- Introduction to part II / Luke Gelinas -- Transparency versus informed consent: the patient/consumer paradigms / Craig J. Konnoth -- Transparency and financial conflicts: the uncertain case for sunshine / Richard S. Saver -- Making religion transparent: the substance, process, and efficacy of disclosing religious restrictions on care / Elizabeth Sepper -- Introduction to part III / Kristin M. Madison -- Transparency on prescription drug research expenditures: a lever for restraining pricing? / Ameet Sarpatwari, Jerry Avorn and Aaron S. Kesselheim -- Is pharmaceutical price transparency an effective means to reduce high prices and wide variations? / Marc A. Rodwin -- Price transparency: a contracts solution / Wendy Netter Epstein -- Solving surprise medical bills / Mark A. Hall -- Introduction to part IV / Holly Fernandez Lynchn -- Increasing the transparency of FDA review to enhance the innovation process / Rachel E. Sachs and Thomas J. Hwang -- Transparency and clinical trial data sharing: legal and policy issues / Barbara E. Bierer, Mark Barnes and Rebecca Li -- The European Medicines Agency's approach to transparency / Stefano Marino and Spyridon Drosos -- Introduction to part V / Gregory Curfman -- The role of transparency in promoting healthy behaviors: pros, cons, and perils of information sharing to foster personal responsibility in health care / Anthony W. Orlando and Arnold J. Rosoff -- The role of transparency in patient safety improvement / Michelle M. Mello, David M. Studdert, Brahmajee K. Nallamothu and Allen Kachalia -- Personal health records as a tool for transparency in health care / Sharona Hoffman -- Nontransparency in electronic health record systems Jim Hawkins, Barbara J. Evans and Harlan M. Krumholz -- Transparency challenges in reproductive health care / Dov Fox -- Introduction to part VI / I. Glenn Cohen -- ERISA as a barrier for state health care transparency efforts / Erin C. Fuse Brown and Jaime S. King -- Transparency and data sharing in clinical research and Big Pharma / Jennifer E. Miller -- Promoting IRB transparency: about what, to whom, why, and how? / Holly Fernandez Lynch -- Using disclosure to regulate PBMs: the dark side of transparency / David A. Hyman and William E. Kovacic
Subject Medical care -- Law and legislation -- United States
Medical ethics -- United States
Informed consent (Medical law) -- United States
Medical care, Cost of -- United States
Delivery of Health Care -- legislation & jurisprudence
Health Policy
Health Care Costs
Ethics, Medical
United States
LAW / Health. bisacsh
Informed consent (Medical law) fast (OCoLC)fst00973191
Medical care, Cost of. fast (OCoLC)fst01013902
Medical care -- Law and legislation. fast (OCoLC)fst01013817
Medical ethics. fast (OCoLC)fst01014081
United States. fast (OCoLC)fst01204155
Alt Author Lynch, Holly Fernandez, editor
Cohen, I. Glenn, editor
Shachar, Carmel, 1985- editor
Record 3 of 3
Record:   Prev Next